AstraZeneca director snaps up shares after one-month low, Computacenter and Essentra directors buy| Director Deals
Michael Demare, non-executive chair of pharmaceutical giant AstraZeneca (AZN) has bought 2,000 shares at £117.93 for a total value of £235,855 on 13 September.
Demare's move comes after the pharmaceutical giant's shares recently fell to a one-month low after the UK's largest quoted company released disappointing data from a late-stage clinical trial of its precision lung-cancer drug DatoDxD....